# UNH — slm-full-gpu

## Metadata

ticker: UNH
arm: slm-full-gpu
judge_prompt_version: v2
context_sha256: 268a0ea190b235c93ad2bfc2b73269985cf48030f0e2f164ba92ba86d270c37c
slm_endpoint: slm-gpu
slm_url: http://132.145.161.150:30880
slm_served_name: qwen3.6-35b-a3b-q4km
slm_artifact: ggml-org/Qwen3.6-35B-A3B-GGUF@baec3ebee244827cda0f4557eafa8b28f7545fa6:Qwen3.6-35B-A3B-Q4_K_M.gguf sha256:671e47e0ec53c665d048b98c3ecbfd5236b5ca9c3e02ed19fc8f81f7b85140c7
slm_build: b11347-5fc4f3c8c
slm_model_path: /models/Qwen3.6-35B-A3B-Q4_K_M.gguf
slm_model_ftype: Q4_K - Medium
slm_total_slots: 4
slm_n_ctx: 32768
slm_n_params: 34660610688
slm_model_size_bytes: 20408576512
slm_thinking: off
slm_sampling: {"planner": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 1024, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.0, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "rag": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 2048, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.1, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "react": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 1024, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.0, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "section": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 768, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.1, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}, "synthesis": {"chat_template_kwargs": {"enable_thinking": false}, "dry_multiplier": 0.0, "frequency_penalty": 0.0, "max_tokens": 4096, "min_p": 0.0, "presence_penalty": 0.0, "repeat_penalty": 1.0, "temperature": 0.2, "top_k": 20, "top_n_sigma": -1.0, "top_p": 0.8, "typical_p": 1.0, "xtc_probability": 0.0}}
llm_calls: 7
llm_endpoints: slm-gpu
llm_by_site: {"rag:highlights": {"calls": 1, "completion_tokens": 637, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 32.983, "latency_s_total": 32.983, "parse_failure": 0, "prompt_tokens": 3060, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "rag:risks": {"calls": 1, "completion_tokens": 496, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 26.228, "latency_s_total": 26.228, "parse_failure": 0, "prompt_tokens": 3049, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:financial_health": {"calls": 1, "completion_tokens": 160, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 15.06, "latency_s_total": 15.06, "parse_failure": 0, "prompt_tokens": 862, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:recent_developments": {"calls": 1, "completion_tokens": 104, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 11.766, "latency_s_total": 11.766, "parse_failure": 0, "prompt_tokens": 856, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:risk_factors": {"calls": 1, "completion_tokens": 158, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 18.857, "latency_s_total": 18.857, "parse_failure": 0, "prompt_tokens": 567, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "section:sec_filing_highlights": {"calls": 1, "completion_tokens": 115, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 17.116, "latency_s_total": 17.116, "parse_failure": 0, "prompt_tokens": 716, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}, "synthesis": {"calls": 1, "completion_tokens": 808, "completion_tokens_unrecorded": 0, "errors": 0, "format_failure": 0, "latency_s_max": 16.554, "latency_s_total": 16.554, "parse_failure": 0, "prompt_tokens": 1450, "prompt_tokens_unrecorded": 0, "repeat_run": 0, "retry": 0, "truncated": 0}}

## Retrieved source context

STOCK DATA:
{
  "ticker": "UNH",
  "company_name": "UnitedHealth Group Incorporated",
  "current_price": 375.98,
  "currency": "USD",
  "market_cap": 337477697536.0,
  "pe_ratio": 24.178778,
  "forward_pe": 16.628786,
  "week_52_high": 461.62,
  "week_52_low": 255.97,
  "financial_currency": "USD",
  "revenue": 450525986816.0,
  "net_income": 14122000384.0,
  "profit_margin_pct": 3.14,
  "dividend_yield": 2.47,
  "sector": "Healthcare",
  "industry": "Healthcare Plans"
}

NEWS ARTICLES:
[
  {
    "title": null,
    "source": null,
    "published_at": null,
    "description": null
  }
]

SEC FILING SUMMARIES:
{
  "10-K": {
    "form_type": "10-K",
    "filing_date": "2026-03-02",
    "summary": "ITEM 1A. RISK FACTORS CAUTIONARY STATEMENTS The statements, estimates, projections or outlook contained in this Annual Report on Form 10-K include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 (PSLRA). When used in this Annual Report on Form 10-K and in future filings by us with the SEC, in our news releases, presentations to securities analysts or investors, and in oral statements made by or with the approval of one of our executive officers, the words \u201cbelieve,\u201d \u201cexpect,\u201d \u201cintend,\u201d \u201cestimate,\u201d \u201canticipate,\u201d \u201cforecast,\u201d \u201coutlook,\u201d \u201cplan,\u201d \u201cproject,\u201d \u201cshould\u201d or similar words or phrases are intended to identify such forward-looking statements. These statements are intended to take advantage of the \u201csafe harbor\u201d provisions of the PSLRA"
  },
  "10-Q": {
    "form_type": "10-Q",
    "filing_date": "2026-08-10",
    "summary": "ITEM 1A. RISK FACTORS In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, Item 1A, \u201cRisk Factors\u201d of our 2025 10-K, which could materially affect our business, financial condition or future results. The risks described in our 2025 10-K are not the only risks facing us. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition or future results. There have been no material changes to the risk factors as disclosed in our 2025 10-K. ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS Issuer Purchases of Equity Securities (a) Second Quarter 2026 For the Month Ended Total Number of Shares Pu"
  }
}

RAG — SEC HIGHLIGHTS:
[From Pinecone cache] Based on the provided text from the Annual Report on Form 10-K for ticker UNH, the key takeaways regarding risk factors and business outlook include:

**Forward-Looking Statements and General Risks**
The report contains forward-looking statements protected under the Private Securities Litigation Reform Act of 1995. These statements involve significant risks and uncertainties that may cause actual results to differ materially from expectations. The company does not undertake to update these statements to reflect events occurring after the report date.

**Medical Cost Management and Profitability**
*   **Risk-Based Products:** Nearly 80% of total consolidated revenues come from risk-based products where the company assumes the risk of medical and administrative costs in exchange for premiums.
*   **Estimation Challenges:** Profitability depends heavily on the ability to accurately predict, price, and manage medical costs. Estimates involve extensive judgment and variability; even small differences between predicted and actual costs can significantly impact financial results.
*   **Cost Drivers:** Actual costs may exceed estimates due to medical inflation, increased service utilization, provider billing intensity, pandemics, climate change effects, new or costly drugs/technologies, and regulatory changes.
*   **Fixed Premiums:** Cost increases exceeding forecasts generally cannot be recovered through higher premiums during the fixed contract period.
*   **Value-Based Care:** For Optum Health’s fully accountable value-based arrangements, failure to deliver higher-quality outcomes at lower costs or to integrate care delivery models could adversely affect financial positions.

**Technology, Data Integrity, and Cybersecurity**
*   **System Integration:** Failure to protect, consolidate, and integrate information systems successfully could lead to higher-than-expected costs. Software products may contain design defects or encounter installation complications.
*   **Data Integrity:** The business relies on the integrity, timeliness, and accuracy of data. Inaccurate, incomplete, or outdated data could lead to product failures, loss of customers, pricing errors, fraud issues, regulatory sanctions, and increased operating expenses.
*   **Cybersecurity Threats:** The company faces ongoing risks from cyberattacks, privacy breaches, and data misappropriation. A notable example cited is a 2024 cyberattack on the acquired Change Healthcare business involving protected health information.
*   **AI and Evolving Tech:** The company anticipates that fast-evolving AI technologies, including generative AI, will play an increasingly important role. However, keeping pace with these technological changes, along with evolving regulations, requires significant resources. Failure to do so could result in reputational harm and adverse business effects.
*   **Third-Party Risks:** The company relies on third-party vendors for data processing, which introduces risks outside of direct oversight.

**Regulatory and Competitive Landscape**
*   **Evolving Regulations:** Uncertain and rapidly evolving laws related to health data and health information technologies (including AI) may alter the competitive landscape and impose new compliance requirements.
*   **Relationships:** Failure to maintain satisfactory relationships with healthcare payers, physicians, hospitals, and other service providers could materially and adversely affect the business.

RAG — RISK FACTORS:
[From Pinecone cache] The primary risk factors disclosed include:

*   **Inaccurate Cost Estimation and Management:** Failure to accurately estimate, price, or manage medical costs and benefit design for risk-based products could materially and adversely affect results of operations, financial position, and cash flows. This is particularly relevant because premium revenues from these products constitute nearly 80% of total consolidated revenues. Actual costs may exceed estimates due to factors such as medical cost inflation, increased service utilization, provider billing intensity, pandemics, climate change effects, new or costly drugs, and regulatory changes. Additionally, estimates for outstanding claims involve significant judgment, and inaccuracies could negatively impact financial results.
*   **Data Integrity and Information Systems:** Failure to maintain the integrity, availability, or security of data, or to successfully consolidate, integrate, upgrade, or expand information systems, could materially and adversely affect the business. Risks include data inaccuracy, system failures, difficulty in pricing products, fraud detection issues, regulatory sanctions, and increased operating expenses. The rapid expansion of health care data and the increasing role of artificial intelligence (AI) require significant ongoing resources to keep pace with technological changes.
*   **Cybersecurity and Data Privacy:** Exposure to cyberattacks, privacy breaches, or data security incidents involving protected personal information or proprietary data could result in revenue loss, increased costs, liability, reputational harm, and operational disruptions. The sophistication of threats, including those leveraging AI, and vulnerabilities in third-party vendors or recently acquired businesses (such as the 2024 cyberattack on Change Healthcare) present ongoing risks.
*   **Relationships with Health Care Providers:** Failure to develop and maintain satisfactory relationships with health care payers, physicians, hospitals, and other service providers could materially and adversely affect the business.
*   **Value-Based Care Performance:** For Optum Health’s fully accountable value-based care, an inability to provide higher-quality outcomes and better experiences at lower costs, or to successfully integrate care delivery models, could impact financial results.
*   **Software and Technology Defects:** Software products sold or installed by the company may contain unexpected design defects or encounter complications during installation or use, which could adversely affect results of operations.
*   **Regulatory and Compliance Risks:** Uncertain and rapidly evolving laws and regulations related to health data and information technologies, including AI, may alter the competitive landscape, impose new compliance requirements, and affect the configuration of information systems.

## Pre-written sections (judge input)

### Financial Health

UnitedHealth Group (UNH) trades at $375.98 with a market capitalization of approximately $337.5 billion, reflecting its dominant position in the healthcare sector. The company reports substantial annual revenue of $450.5 billion, though its current net profit margin stands at a modest 3.14%. With a trailing P/E ratio of 24.18, the stock appears moderately valued relative to historical earnings, while the forward P/E of 16.63 suggests anticipated earnings growth. This valuation gap indicates that investors are pricing in improved profitability or operational efficiency in the near term. Overall, the financial profile demonstrates strong top-line scale with a focus on margin expansion as a key driver for future value.

### Recent Developments

UnitedHealth Group has filed its 2026 10-K and 10-Q reports, with the latter confirming no material changes to the risk factors previously disclosed in the annual filing. The company continues to execute its capital return strategy, as evidenced by ongoing share repurchase activities detailed in the second quarter 2026 equity securities report. Investors should monitor these filings for any emerging regulatory or operational risks that could impact the company's forward-looking guidance and long-term profitability.

### SEC Filing Highlights
Nearly 80% of UnitedHealth Group’s consolidated revenues are derived from risk-based products, making profitability highly sensitive to the accuracy of medical cost estimates and the impact of inflation or utilization trends. The company faces significant operational risks from cybersecurity threats, notably highlighted by the 2024 Change Healthcare breach, as well as potential liabilities from data integrity failures and third-party vendor dependencies. Additionally, UNH must navigate an evolving regulatory landscape and rapidly advancing AI technologies, where failure to adapt could result in reputational harm and increased compliance costs.

### Risk Factors

*   **Medical Cost Estimation and Pricing:** Inaccurate estimation of medical costs or benefit design for risk-based products—which constitute nearly 80% of consolidated revenues—could materially adversely affect financial results due to factors such as medical inflation, utilization changes, and regulatory shifts.
*   **Cybersecurity and Data Integrity:** The company faces significant risks from cyberattacks, data privacy breaches, and system failures, including those stemming from third-party vendors and recent acquisitions, which could lead to operational disruptions, regulatory sanctions, and reputational harm.
*   **Regulatory and Compliance Uncertainty:** Rapidly evolving laws and regulations regarding health data, information technologies, and artificial intelligence may impose new compliance burdens, alter the competitive landscape, and increase operating expenses.

## Audited (Exec Summary + Outlook)

### Executive Summary
UnitedHealth Group (UNH) is a dominant force in the healthcare sector, generating $450.5 billion in annual revenue and maintaining a market capitalization of approximately $337.5 billion. The stock is currently notable for its valuation gap, where a forward P/E of 16.63 suggests anticipated earnings growth despite a trailing P/E of 24.18, indicating that investors are pricing in improved profitability. The single most important near-term variable shaping the outcome is the company’s ability to execute margin expansion while managing the sensitivity of its risk-based products to medical cost estimates and inflation.

### Outlook
The directional outlook for UnitedHealth Group is cautiously constructive, anchored by its massive scale and the market’s expectation of margin expansion reflected in the forward valuation. Key variables to monitor include the trajectory of medical cost trends, the effectiveness of cybersecurity defenses following the Change Healthcare incident, and the company’s ability to adapt to evolving AI and regulatory frameworks. The thesis would be strengthened by consistent evidence of operational efficiency gains and stable utilization rates, whereas a deterioration in medical cost estimates or a significant regulatory setback regarding data privacy would weaken the investment case.

---
*This brief is for informational purposes only and does not constitute financial advice.*

## Judge findings

I will now systematically identify every specific quantitative figure, price target, threshold, ratio, metric, percentage, named product milestone, or forward-looking number in the **Executive Summary** and **Outlook** sections, then evaluate each one.

---

**EXECUTIVE SUMMARY**

---

CLAIM: "$450.5 billion in annual revenue"
LABEL: SUPPORTED
REASON: Source data shows revenue of $450,525,986,816, which rounds to $450.5 billion; the Pre-written Financial Health section also states "$450.5 billion."

---

CLAIM: "market capitalization of approximately $337.5 billion"
LABEL: SUPPORTED
REASON: Source data shows market_cap of $337,477,697,536, which rounds to approximately $337.5 billion; confirmed in the Pre-written Financial Health section.

---

CLAIM: "forward P/E of 16.63"
LABEL: SUPPORTED
REASON: Source data shows forward_pe of 16.628786, which rounds to 16.63; confirmed in the Pre-written Financial Health section.

---

CLAIM: "trailing P/E of 24.18"
LABEL: SUPPORTED
REASON: Source data shows pe_ratio of 24.178778, which rounds to 24.18; confirmed in the Pre-written Financial Health section.

---

**OUTLOOK**

---

CLAIM: "the Change Healthcare incident"
LABEL: SUPPORTED
REASON: The 2024 cyberattack on Change Healthcare is explicitly referenced in both the RAG SEC Highlights and the Pre-written SEC Filing Highlights sections.

---

*(No additional quantitative figures, price targets, thresholds, ratios, metrics, percentages, named product milestones, or forward-looking numbers appear in the Outlook section beyond the qualitative directional statements and the named event above.)*

---

**SUMMARY TABLE**

| # | Claim | Label |
|---|-------|-------|
| 1 | $450.5 billion in annual revenue | SUPPORTED |
| 2 | Market cap ~$337.5 billion | SUPPORTED |
| 3 | Forward P/E of 16.63 | SUPPORTED |
| 4 | Trailing P/E of 24.18 | SUPPORTED |
| 5 | Change Healthcare incident (named event) | SUPPORTED |

All five auditable claims in the Executive Summary and Outlook are fully supported by the source data. No unsupported or inference-only claims were identified.
